GSK241206C28000
- 0.00
- 0.000.00%
GlaxoSmithKline Newsroom
GSK Partners With Rgenta Therapeutics to Develop Small Molecule Splice Modulators
First Single-dose Medicine for P. Vivax Malaria Prequalified by WHO and Included in WHO Guidelines
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Marjorie Taylor Greene Discloses Buys of AMD, Alphabet, Microsoft, Others
Berenberg Lowers Price Target on GSK to GBP16 From GBP18.20, Maintains Buy Rating
Berenberg Bank Sticks to Its Buy Rating for GlaxoSmithKline (GSK)
Trump 'sells off' European pharmaceutical stocks, can only rely on 'Americanization' to stop the decline?
The growth prescription for European pharmaceutical companies: shifting towards the usa.
UK Shares Tick Up as Market Watchers Await Key US Inflation Data
European Commission Approves Products by BeiGene, GSK and Novartis
Express News | Vice Minister of Commerce Ling Ji met with the Chairman of the Sino-British Trade Association, Gu Peiqin.
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
GSK's Fully Liquid Menveo Meningococcal Vaccine Approved By European Commission
Express News | glaxosmithkline's meningitis vaccine has been approved by the European Union
GSK's Liquid Meningitis Vaccine Gets EU Authorization
Bird Flu Found In Raw Milk Leads To Recall In California
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
FDA Accepts GSK's BLA for Blenrep Combos in Multiple Myeloma
Optimistic Buy Rating for GlaxoSmithKline: Undervalued Stock With Promising Growth Prospects
Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
GSK Cancer Therapy Candidate Accepted for FDA Review